Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study
Lebrikizumab治疗成人和青少年有色皮肤中重度特应性皮炎患者的疗效和安全性：来自IIIb期开放标签ADmirable研究的结果
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00970-8
Alexis, Andrew; Moiin, Ali; Waibel, Jill; Wallace, Paul; Cohen, David; Laquer, Vivian; Kwong, Pearl; Atwater, Amber Reck; Schuster, Christopher; Proper, Jennifer; Silk, Maria; Pierce, Evangeline; Pillai, Sreekumar; Rueda, Maria Jose; Moore, Angela
